ziconotide (Prialt)

Tradename: Prialt (FDA-approved in 2004) Indications: - severe chronic pain Dosage: Intrathecal agent Mechanism of action: - synthetic peptide analagesic Notes: Manufacturer: Elan

General

analgesic (antalgic) peptide

References

- Prescriber's Letter 12(2): 2005 New Drugs Approved by the FDA in 2004 Detail-Document#: 210216 (subscription needed) http://www.prescribersletter.com